Preoperative GLP-1 Receptor Agonist Use and Weight Loss Outcomes Following Bariatric Surgery

Preoperative GLP-1 use was not associated with postoperative weight loss in a statewide, multi-system cohort, including in an active-comparator analysis among patients with type 2 diabetes. These findings suggest preoperative GLP-1 therapy is unlikely to compromise MBS weight loss outcomes.